Albany, NY -- (SBWIRE) -- 04/14/2015 -- Deep vein thrombosis (DVT) or pulmonary embolism (PE) is the most chronic clinical condition and there diagnosis methods are expected to be time-efficient and precise detection. As in case of acute PE, medication preventing thrombosis also carries a bleeding risk which might cause further complications. Hence, to prevent this diagnostics plays a major role in clinical evaluation, diagnostic imaging and D-dimer testing. D-dimer is the product produced by regular clotting process and is available in miniscule quantities in the blood it is mainly formed after degradation of cross-linked (factor XIII) fibrin. In clinical conditions like DVT and PE the normal concentration of D-dimer elevates owing to increase in body's clotting activity. D-drimers are not present actively in human plasma but are activated when the coagulation system is triggered. The normal concentration of D-dimer for reference is less than 0.5µ/mL FEU (fibrogen equivalent units).

Early buyers will receive 10% customization on reports:- http://www.transparencymarketresearch.com/d-dimer-market.html

The D-dimer testing market can be segmented on the basis of applications such as evaluation of thrombus development, DVT detection, anti-coagulant treatment monitoring, disseminated intravascular coagulation (DIC) and snake venom poisoning. In addition, D-dimer concentration also increases in conditions such as pregnancy, inflammation, postsurgical treatment, trauma, malignancy, heart disease, liver disease and sometimes it was observed high in hospitalized patients. According to American Society for Clinical Pathology, in adult patients with a clinically low pretest probability of developing DVT, a negative D-dimer test result yields a 99% negative predictive value (NPV) in patients aged 60-80 years; but only a 21%-31% NPV in patients older than 80 years. Hence, this highlights the fact that in case patients with high pretest probability of developing DVT, D-dimer has no vital clinical efficacy.

According to Centers for Disease Control and Prevention (CDC), The estimated range of people affected by DVT/PE is between 300,000 to 600,000 (1 to 2 per 1,000, and in those over 80 years of age, as high as 1 in 100) each year in the United States. The growing prevalence of DVT and other genetic disorders related with circulatory system are expected to drive the D-dimer testing market. A usage attribute that makes D-dimer testing as a method of choice is because its becoming more standardized in nature compared to earlier test kits this has developed opportunities for current market players as well as upcoming players, the quality control products and services have high demand in the market.

North America is the largest D-drimer testing market because of factors such as high prevalence rate of DVT; some of the key players domiciled in this region and technologically upgraded test kits available in the market. Europe is observed to be more stabilized market owing to technological awareness among the stakeholders and high market demand for more efficient D-drimer kits are assisting its market growth. Asia-Pacific and Rest of the World (RoW) are expected to grow with significant pace as most of the countries from this region are away from technologically advanced diagnostic techniques and there is high demand for technologically developed diagnostic test kits for their accuracy. Brazil, India, China, Mexico, South Korea and Japan are observed to be the most potential D-dimer markets worldwide.

Some of the key players in D-dimers testing market are Abbott Laboratories, American Diagnostica GmbH, Avocet Medical,Inc., Beckman Coulter,Inc., Becton, Dickinson and Company, HYPEN BioMed, Chrono-Log Corporation, Trinity Biotech PLC, Helena Laboratories, Thermo Fischer Scientific,Inc., Siemens and others

More Reports on Medical Devices Market : http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

This research report analyses this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

- North America
- Asia Pacific
- Europe
- Rest of the World

This report provides comprehensive analysis of

- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porters five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Enquiry Before Buying :- http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2398

About TMR
TMR's analysts and consultants are distinguished experts in their respective domains. The company is based on an employee-centric model and hires the best, brightest, and most passionate people in the industry. This unparalleled expertise helps TMR uncover latest market intelligence data that's distinct from the competition.

TMR is also a client-centric organization that endeavors to add value to the client's business by delivering the most insightful research. TMR understands that every client has unique product/service offerings, statement, and criteria. Customized solutions from TMR are centered on the client's problem statement. On the other hand, our syndicated research reports provide a packaged solution to keep enterprises abreast of the next major change in their industry.

Contact:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Browse Market Research Blog:
http://researchreportsindustry.wordpress.com/